Our Global Oncology program is also advancing collaboration between researchers at Fred Hutch and scientists in China, including research on cancer genomics, immunology and infectious diseases, ...

NEW YORK, December 03, 2024--The Morgan Stanley China A Share Fund, Inc. (the "Fund") today declared the following dividend. NEW YORK, February 23, 2024--Morgan Stanley China A Share Fund ...

Morgan Stanley terminated its membership of a major climate-banking group, joining a wave of Wall Street firms that recently quit a global alliance intended to aid the reduction of greenhouse-gas ...

Morgan Stanley on Thursday announced its departure from a coalition of banks that aims to target net-zero emissions through lending and investment, the fifth group to do so in recent weeks.

Hutchmed (HCM) announces that the new drug application for the combination of Orpathys and Tagrisso for the treatment of patients with locally advanced or metastatic epidermal growth factor ...

China Virus Outbreak News: There is no confirmation from Chinese health officials or the WHO regarding any such epidemic or state of emergency in China. Though users on Social media are sharing about ...

China's NMPA granted priority review to the Orpathys-Tagrisso NDA. The NDA was based on data from the Phase III SACHI trial, which compared the Orpathys-Tagrisso combination to platinum-based ...

Left tackle Ronnie Stanley and defensive tackle Nnamdi Madubuike returned to practice as limited participants after being sidelined by illnesses. However, some Ravens are still under the weather ...

China’s go-go days are behind it as the world’s second-largest economy struggles with the bursting of the biggest real-estate bubble ever. Now, China’s goal of overtaking the U.S. as the ...

By Daisuke Wakabayashi and Claire Fu China’s top leader, Xi Jinping, veered momentarily from his usual talking points in a New Year’s address to acknowledge the challenges of the country’s ...

In the televised address, Xi acknowledged that China’s economy was facing “challenges from uncertainties in the external environment” — but he struck a defiant note, proclaiming that the ...

The NDA is supported by data from SACHI, a multi-center, open-label, randomized, controlled, Phase III trial which evaluated the efficacy and safety of a combination of ORPATHYS® and TAGRISSO ...